GRAMINEX L.L.C. expands its partnership with IDIPharma after clinical study publication.
Graminex® LLC, producer of Non-Solvent Graminex® Flower Pollen Extracts™, is pleased to announce the expansion of its partnership with IDIPharma. After completion and publication of clinical studies supporting the use of Graminex® Flower Pollen Extract™ for Prostate Pain and Chronic Pelvic Pain (CCP), IDIPharma and Graminex® have agreed to expand clinical research on Graminex® Flower Pollen Extract™.
“Graminex® looks forward to expanding its relationship with IDIPharma, producer of DEPROX® 500 containing Non-Solvent Graminex® Flower Pollen Extract™. IDIPharma has proven its outstanding commitment to quality by delivering substantiated products to its customers,” stated Justin E Ritter, Regulatory Affairs.
“IDIPharma is committed to solving gynecological, urological and andrological problems by its continued scientific collaboration within the medical community. Deprox® 500, which contains Non-Solvent Graminex® Flower Pollen Extract™, was the first Italian Supplement strongly focused on prostatitis. Deprox® is supported by clinical studies that underline the distinctiveness of its formulation and its real effectiveness in regards to the long standing problems of prostatitis,” stated Dora Arena, Ph.D.
About Graminex ® LLC
Graminex® LLC is the leading producer of natural and solvent free Graminex® Flower Pollen Extract™. Graminex® directly owns and manages more than 8,500 acres of farmland in Northwest Ohio. Graminex’s® active raw ingredients are grown and processed for use in the dietary supplement, pharmaceutical, food and skincare industries. Graminex® markets clinically supported Flower Pollen Extracts, focusing on prostate care, urinary care, menopausal support, and skin care. Partnered with its distributors, retailers and manufacturers, Graminex® products are sold in more than 44 countries.
About IDI Integratori Dietetic Italiana S.r.l.
IDIPharma is a pioneer and leader in the Italian phyto-market, focusing on urological diseases. Each year IDIPharma sponsors several Italian and European Urological Congresses to increase the awareness of Deprox® through urologists and publicizing results of clinical studies containing Non-Solvent Graminex® Flower Pollen Extracts™.
Colleen E. May
2-300 County Road C
Deshler, Ohio 43516
Dora Arena, Ph.D.
IDI Integratori Dietetici Italiani S.r.l.
Via G. Mameli 12
95020 ACI BONACCORSI (CT)
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
CA-VISA-INC.17.10.2018 14:02 | pressemeddelelse
Visa Unveils New Partners on Tokenization to Help Increase Payment Security and Reduce Effects of Data Breaches
NY-MOODY'S-CORPORATION17.10.2018 13:02 | pressemeddelelse
Moody’s Names Derek Vadala as Global Head of Cyber Risk for MIS
SHARJAH17.10.2018 12:31 | pressemeddelelse
Nadia Murad to Speak at Sharjah Conference Aimed at Boosting Opportunities for MENA’s Youth
BENTLEY-SYSTEMS17.10.2018 11:00 | pressemeddelelse
Bentley Systems Releases Open-Source Library: iModel.js
IL-PROJECT4417.10.2018 09:02 | pressemeddelelse
project44 and Gatehouse Logistics Announce Exclusive Partnership
MA-WHOOP17.10.2018 09:02 | pressemeddelelse
WHOOP, the Human Performance Company, Launches in Europe
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum